TSC22D2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.900800E-01
Normal-vs-Stage2
4.932400E-01
Normal-vs-Stage3
5.210000E-01
Normal-vs-Stage4
1.100790E-01
Stage1-vs-Stage2
5.877700E-03
Stage1-vs-Stage3
7.860400E-01
Stage1-vs-Stage4
7.463700E-02
Stage2-vs-Stage3
1.597190E-01
Stage2-vs-Stage4
8.517800E-03
Stage3-vs-Stage4
3.800000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.853200E-01
Normal-vs-AfricanAmerican
6.402600E-01
Normal-vs-Asian
8.129200E-01
Caucasian-vs-AfricanAmerican
9.830200E-01
Caucasian-vs-Asian
6.564800E-01
AfricanAmerican-vs-Asian
8.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.237200E-01
Normal-vs-Female
5.215600E-01
Male-vs-Female
6.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.923000E-01
Normal-vs-Age(41-60Yrs)
2.369400E-01
Normal-vs-Age(61-80Yrs)
7.752800E-01
Normal-vs-Age(81-100Yrs)
7.612000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.488800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.958190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.719400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.037900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.178100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.242200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.709200E-01
Normal-vs-Daily Drinker
9.836000E-01
Normal-vs-Weekly Drinker
6.022000E-01
Normal-vs-Occasional Drinker
4.726200E-01
Normal-vs-Social Drinker
5.197000E-01
Non Drinker-vs-Daily Drinker
3.013800E-01
Non Drinker-vs-Weekly Drinker
8.012200E-01
Non Drinker-vs-Occasional Drinker
5.712000E-01
Non Drinker-vs-Social Drinker
6.372400E-01
Daily Drinker-vs-Weekly Drinker
2.467400E-01
Daily Drinker-vs-Occasional Drinker
1.122440E-01
Daily Drinker-vs-Social Drinker
1.551440E-01
Weekly Drinker-vs-Occasional Drinker
8.136800E-01
Weekly Drinker-vs-Social Drinker
8.604000E-01
Occasional Drinker-vs-Social Drinker
9.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.772990E-01
Normal-vs-Grade 2
1.471950E-02
Normal-vs-Grade 3
3.833700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.004700E-03
Grade 1-vs-Grade 3
6.640400E-03
Grade 1-vs-Grade 4
1.772990E-01
Grade 2-vs-Grade 3
6.609000E-01
Grade 2-vs-Grade 4
1.471950E-02
Grade 3-vs-Grade 4
3.833700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.748600E-01
Normal-vs-NonDiabetic
6.190000E-01
Diabetic-vs-NonDiabetic
8.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.051200E-01
Normal-vs-NoPancreatitis
6.399200E-01
Pancreatitis-vs-NoPancreatitis
3.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.243200E-01
Normal-vs-N1
4.618800E-01
N0-vs-N1
1.027350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.129200E-01
Normal-vs-TP53-NonMutant
8.268000E-01
TP53-Mutant-vs-TP53-NonMutant
4.791700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
